Searching For Real Value In Market Debris At Athira Pharma Inc (NASDAQ: ATHA)

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, ATHA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Athira Pharma Inc is $12.20M. A total of 6.19 million shares were traded on the day, compared to an average of 230.69K shares.

In the most recent transaction, San Martin Javier sold 10,826 shares of ATHA for 0.56 per share on Jan 02 ’25. After the transaction, the CHIEF MEDICAL OFFICER now owns 35,841 company shares. In a previous transaction on Jan 02 ’25, Litton Mark James sold 25,107 shares at 0.56 per share. ATHA shares that President and CEO owns now total 242,591.

Among the insiders who sold shares, CHURCH KEVIN disposed of 8,510 shares on Jan 02 ’25 at a per-share price of $0.56. This resulted in the CHIEF SCIENTIFIC OFFICER holding 130,761 shares of ATHA after the transaction. In another insider transaction, Renninger Robert sold 2,881 shares at $0.56 per share on Jan 02 ’25. Company shares held by the VP of Finance now total 89,724.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ATHA has a high of $3.67 and a low of $0.22.

As of this writing, ATHA has an earnings estimate of $0 per share for the current quarter.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ATHA’s latest balance sheet shows that the firm has $253.76M in Cash & Short Term Investments as of fiscal 2021. There were $1.92M in debt and $9.29M in liabilities at the time. Its Book Value Per Share was $0.96, while its Total Shareholder’s Equity was $321.08M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ATHA is Buy with a score of 3.00.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.